Jash Datta: Inside the Translational Research Enterprise at Sylvester Comprehensive Cancer Center - Oncodaily
Jash Datta: Inside the Translational Research Enterprise at Sylvester Comprehensive Cancer Center Oncodaily
Pancreatic Cancer News
Scientists discover an unexpected way to make pancreatic cancer cells self-destruct - ScienceDaily
Scientists discover an unexpected way to make pancreatic cancer cells self-destruct ScienceDaily
Doctors say new pancreatic cancer drug is giving hope to advanced stage patients - WAVY.com
Doctors say new pancreatic cancer drug is giving hope to advanced stage patients WAVY.com
New pancreatic cancer pill shows promise in extending survival time: HealthLink - KING5.com
New pancreatic cancer pill shows promise in extending survival time: HealthLink KING5.com
Vitamin D analog shuts down pancreatic cancer's shield in a clinical trial - Medical Xpress
Vitamin D analog shuts down pancreatic cancer's shield in a clinical trial Medical Xpress
New pancreatic cancer pill nearly doubles survival time in breakthrough trial - Fox News
New pancreatic cancer pill nearly doubles survival time in breakthrough trial Fox News
After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses - NBC News
After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses NBC News
Daily pill can double survival time for world’s deadliest cancer, trial shows - The Guardian
Daily pill can double survival time for world’s deadliest cancer, trial shows The Guardian
Pancreatic cancer halted by virus injection in three patients - New Scientist
Pancreatic cancer halted by virus injection in three patients New Scientist
Revolution Medicines starts shipping experimental pancreatic cancer drug - statnews.com
Revolution Medicines starts shipping experimental pancreatic cancer drug statnews.com
Doctors hail a new treatment for pancreatic cancer - WHRO
Doctors hail a new treatment for pancreatic cancer WHRO
A pancreatic cancer drug provides new hope: Five things to know about daraxonrasib - Stanford Medicine
A pancreatic cancer drug provides new hope: Five things to know about daraxonrasib Stanford Medicine
At a Turning Point for RAS-directed Therapies, Break Through Cancer and the Lustgarten Foundation Launch New Pancreatic Cancer Initiative - PR Newswire
At a Turning Point for RAS-directed Therapies, Break Through Cancer and the Lustgarten Foundation Launch New Pancreatic Cancer Initiative PR Newswire
Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise - The Cancer Letter
Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise The Cancer Letter
Pancreatic Cancer | Summer 2026 Synthesis | UC Davis Comprehensive Cancer Center - University of California - Davis Health
Pancreatic Cancer | Summer 2026 Synthesis | UC Davis Comprehensive Cancer Center University of California - Davis Health
Revolution’s second RAS blocker doubles chemo response rate in pancreatic cancer - BioSpace
Revolution’s second RAS blocker doubles chemo response rate in pancreatic cancer BioSpace
Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis - Nature
Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis Nature
A new pancreatic cancer drug is changing survival rates for one of the deadliest cancers - UCHealth
A new pancreatic cancer drug is changing survival rates for one of the deadliest cancers UCHealth
How Daraxonrasib Could Improve Pancreatic Cancer Treatment, Offering New Hope - Memorial Sloan Kettering Cancer Center
How Daraxonrasib Could Improve Pancreatic Cancer Treatment, Offering New Hope Memorial Sloan Kettering Cancer Center
New Drug Shows Survival Gains in Pancreatic Cancer - AARP
New Drug Shows Survival Gains in Pancreatic Cancer AARP
New pancreatic cancer drug program may help rural patients get treatment closer to home - WHRO
New pancreatic cancer drug program may help rural patients get treatment closer to home WHRO
Pancreatic cancer experts, patients applaud new KRAS inhibitor therapy - Fred Hutchinson Cancer Center
Pancreatic cancer experts, patients applaud new KRAS inhibitor therapy Fred Hutchinson Cancer Center
Landmark pancreatic cancer treatment paves way for targeting other tricky tumors - Scientific American
Landmark pancreatic cancer treatment paves way for targeting other tricky tumors Scientific American
New drug could double survival time in patients with advanced pancreatic cancer - News-Medical
New drug could double survival time in patients with advanced pancreatic cancer News-Medical
Winning the lottery with a clinical trial to treat pancreatic cancer - UCLA Health
Winning the lottery with a clinical trial to treat pancreatic cancer UCLA Health
Daraxonrasib Extends Median Survival in Previously Treated Pancreatic Cancer - The ASCO Post
Daraxonrasib Extends Median Survival in Previously Treated Pancreatic Cancer The ASCO Post
A new drug targets one of cancer’s master switches - The Economist
A new drug targets one of cancer’s master switches The Economist
Experimental Drug Doubles Median Survival in Patients With Metastatic Pancreatic Cancer - Harvard Medical School
Experimental Drug Doubles Median Survival in Patients With Metastatic Pancreatic Cancer Harvard Medical School
Promising new treatment for pancreatic cancer doubles survival rates - PBS
Promising new treatment for pancreatic cancer doubles survival rates PBS
Dad’s indigestion was sign of pancreatic cancer - Discover SWNS
Dad’s indigestion was sign of pancreatic cancer Discover SWNS
Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease - The Conversation
Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease The Conversation
Q&A: What does the new ‘game-changer’ pill offer pancreatic cancer patients? - UVA Today
Q&A: What does the new ‘game-changer’ pill offer pancreatic cancer patients? UVA Today
Experimental pill could change treatment for advanced pancreatic cancer - ConsumerAffairs
Experimental pill could change treatment for advanced pancreatic cancer ConsumerAffairs
Cosimo Commisso: Presenting New Pancreatic Cancer Drug Discovery Research at MUSC - Oncodaily
Cosimo Commisso: Presenting New Pancreatic Cancer Drug Discovery Research at MUSC Oncodaily
Experimental Treatment Strategy Shows Promise Against Advanced Pancreatic Cancer - The University of Oklahoma
Experimental Treatment Strategy Shows Promise Against Advanced Pancreatic Cancer The University of Oklahoma
Roundup: Drug Under Study Extends Survival Time in Advanced Pancreatic Cancer Cases; and More News - Baptist Health
Roundup: Drug Under Study Extends Survival Time in Advanced Pancreatic Cancer Cases; and More News Baptist Health
Grand Rapids oncologist says experimental pancreatic cancer drug showing promise in trials offers hope - WZZM13.com
Grand Rapids oncologist says experimental pancreatic cancer drug showing promise in trials offers hope WZZM13.com
The real work for making dramatic gains against pancreatic cancer is just beginning - statnews.com
The real work for making dramatic gains against pancreatic cancer is just beginning statnews.com
UCLA-led study discovers breakthrough in pancreatic cancer treatment - CBS News
UCLA-led study discovers breakthrough in pancreatic cancer treatment CBS News
One fat helped pancreatic cancer grow while another cut disease in half - ScienceDaily
One fat helped pancreatic cancer grow while another cut disease in half ScienceDaily